FamicordtxS.A.Active
Research and experimental development on biotechnology
KRS: 0000799177 NIP: 5223166042 REGON: 38412405500000
Overview
Registry date
2019-08-14
Share capital
$142,679.63
Activity description
Famicordtx is a biotech company focused on developing cell and gene therapies, specifically working on creating the world's first CAR-T cancer therapy based on an allogeneic populational bank. They aim to provide advanced immunotherapy for patients with hematological cancers by using genetically modified T lymphocytes. The company operates under stringent GMP standards for drug manufacturing and collaborates with global scientists and clinicians.
Registered address
Ul. Działkowa 85, 02-234 Warszawa, Poland
Website
famicordtx.comWebsite active
Electronic delivery address
AE:PL-67346-53035-RGSHD-08
Industry
Accounts
Registered as a VAT taxpayer on 2019-08-26.Active
- 46 1020 1026 0000 1102 0392 8942
- 36 1020 1026 0000 1502 0392 8926
- 36 1020 1026 0000 1802 0392 8876
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| BiotechnaS.A. | $2,465,682.50 | bsbiotechna.com | |
| Read-GeneS.A. | $1,632,134.59 | read-gene.com | |
| GenomtecS.A. | $931,086.83 | genomtec.com | |
| GenxoneS.A. | $542,750.94 | genxone.eu | |
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | |
| BiottsS.A. | $372,115.60 | biotts.com | |
| Medicofarma BiotechS.A. | $330,956.61 | medicofarmabiotech.pl | |
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | |
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | |
| UveraS.A. | $155,384.29 | uvera.eu |
Change history
| Event | Details | Date | |
|---|---|---|---|
| Share capital change | 140200.00 PLN → 528200.00 PLN | 2026-05-13 |
FAQ
Last updated: 2026-05-13